Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Work In Process (2022 - 2025)

Jin Medical International's Work In Process history spans 4 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Work In Process rose 9.45% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $1.9 million, up 9.45%, while the annual FY2025 figure was $1.9 million, 9.45% up from the prior year.
  • Work In Process for Q3 2025 was $1.9 million at Jin Medical International, up from $1.7 million in the prior quarter.
  • Across five years, Work In Process topped out at $1.9 million in Q3 2025 and bottomed at $1.4 million in Q3 2022.
  • The 4-year median for Work In Process is $1.7 million (2023), against an average of $1.7 million.
  • The largest annual shift saw Work In Process grew 15.35% in 2023 before it increased 8.16% in 2024.
  • A 4-year view of Work In Process shows it stood at $1.4 million in 2022, then rose by 15.35% to $1.6 million in 2023, then grew by 8.16% to $1.7 million in 2024, then grew by 9.45% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for ZJYL's Work In Process are $1.9 million (Q3 2025), $1.7 million (Q3 2024), and $1.6 million (Q3 2023).